 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Investor Relations
Cadence Pharmaceuticals, Inc. is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting.
Recent Releases
Nov 5, 2009
Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results
Events
Nov 13, 2009
Cadence Pharmaceuticals Conference Call
Nov 5, 2009
Cadence Pharmaceuticals 3rd Quarter 2009 Earnings Release
| Stock Quote |
|---|
| CADX - (NASDAQ)
$8.70 + 0.03 Nov 20, 2009 4:12 PM ET |
Quotes delayed at
least 20 minutes.
Information provided
by eSignal.